Stock Track | Ali Health Plummets 5.07% Intraday Amid Sector Weakness, UBS Sell Rating and Institutional Outflows

Stock Track07-14 11:05

Ali Health's stock plummeted 5.07% during intraday trading on Tuesday, reflecting significant selling pressure in the medical e-commerce sector.

The decline was driven by broad weakness in the medical e-commerce sector for a second consecutive session, with peers JD Health and PA Good Doctor also falling sharply. Additionally, UBS maintained its sell rating on Ali Health and lowered its target price to HK$3.1, with the current share price converging toward this bearish target.

Persistent institutional outflows further weighed on sentiment, as southbound capital cumulatively net sold over 128 million shares over the past 20 trading days. Despite Ali Health reporting robust FY2026 results with revenue growth of 12% and net profit growth of 35.2%, bearish analyst positioning and weak capital flows dominated near-term price action.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment